Novo Nordisk $NVO just filed a lawsuit against Eli Lilly $LLY
Novo alleges that Eli Lilly's ads for its weight loss drugs are designed to "mislead consumers about their superior efficacy" relative to Novo Nordisk's injections - CNBC
π’ BULLISH OPEN TODAY
US futures point higher this morning: Dow +0.36%, S&P 500 +0.44%, Nasdaq +1.02% π
Chip stocks lead the rebound after last week's pullback, with Asian semis rallying hard. Samsung & TSMC up ~3%. Oil cooling below $89 also eases inflation fears.
US markets eyeing a cautious open after Fridayβs pullback. π S&P 500 -1%, Nasdaq hit harder ~1.5% as VIX spiked +12% to 18.8. Futures flat to mildly green this morning tentative bounce possible, but geopolitics (Iran tensions) + earnings season keep vol in focus. π
Thesis check: The Odyssey didn't "moon" these stocks because the market had already priced in Nolan's track record.
But the data confirms the structural shift, IMAX format revenue share hit 25% of domestic opening. That's not a movie bet, that's a format bet.
The real story: P/E ~4.6, dividend yield ~5.6%, and insider buying on IBKR. The studio win is nice, but you're buying the cash flow machine, not the blockbuster.
$ISRG 3.39% went from -6.85% to -20.4%. Ouch. Robotic surgery getting hit hard.
$VICI 13.88% went from -5.44% to -6.62%. REITs still under pressure.
$TROW 5.75% went from +22.7% to +21.4%. Small pullback after big run.
90 bps above SP
Biggest movers this week:
$NVO 18.28% went from +14.2% to +16.1%. GLP-1 rally continues, stock at $50.31.
$META 12.93% went from +9.76% to +5.01%. Gave back some gains, still green though.
π U.S. stocks eye a BEARISH open Friday: $NFLX sinks ~8% AH on a mixed Q2, the chip rout enters day 2, and Brent holds near multi-week highs on the U.S.βIran standoff. 10Y at 4.58% adds pressure on tech. Watch energy & semis.